GLP-1 Postpartum: When and How Moms Actually Start

I wanted a date. There isn't one.

What I wanted, standing on the bathroom scale eleven weeks after my second was born, was somebody to tell me the week I was allowed to start. There is no such week, and it took me a while to accept that.

What I got instead was a set of gates: a GLP-1 isn't for use during pregnancy or while trying to conceive, the breastfeeding decision is a separate call you make with your clinician, and reliable contraception matters once you start. For me — and for most moms I've compared notes with — the practical window opened once I was done nursing and my body had had time to settle. I'll walk each gate the way I had to, with the receipts.

I'm a peer, not your doctor. This is education about how the timing tends to work, not a personalized clearance to start.

Why I refused to feel silly about wanting this

The thing nobody said out loud to me: postpartum weight retention is real, it's common, and it isn't a character flaw. A large meta-analysis found that higher gestational weight gain is associated with meaningfully greater weight retention years later¹. Reading that did something for me that no pep talk had — the weight I was still carrying wasn't a verdict on how hard I was trying, it was a documented pattern. Wanting a real tool was reasonable.

And the tool works. Once-weekly semaglutide produced about 15% average body-weight loss in adults with overweight or obesity in its pivotal trial². That number is why I kept the tab open for three months. But "it works" and "start today" are different sentences, and the when is where being postpartum actually mattered for me.

Gate one: pregnancy and trying to conceive

GLP-1 medicines are not for use in pregnancy or while trying to conceive — the systematic-review evidence across preconception and pregnancy is limited and cautionary, and the labels reflect that³. We weren't certain we were done having kids when I first looked into this, and that turned out to be the conversation I needed to have with my clinician before starting, not after. Every responsible intake I walked asked me this outright. A program that doesn't ask should worry you.

Gate two: breastfeeding

I was still nursing, so this was my gate for months. The milk-transfer data for semaglutide is cautiously reassuring — it wasn't detectable in the milk of the mothers studied, and GLP-1s are large peptides that transfer in tiny amounts and are likely broken down in an infant's gut⁴ — but the human safety data is thin enough that the labels still advise against use while breastfeeding. I unpack the whole thing in GLP-1 while breastfeeding: the real-talk safety rundown, including the 2am version of me who read all of it on a phone.

For timing, the short version: I planned to start after weaning. Other moms I know had an individualized conversation with their OB, pediatrician or prescriber instead. Either way it's a clinician call, not a form to breeze past.

Gate three: contraception, the one I nearly missed

This is the gate that almost caught me out. Because a GLP-1 isn't for use in pregnancy, reliable contraception matters once you start — and there's a specific pharmacology wrinkle I did not know about. These medicines slow gastric emptying, and for tirzepatide in particular that can reduce the absorption and effectiveness of oral contraceptive pills, especially around dose increases⁵. I was on the pill and assuming I was covered. I wasn't necessarily. If that's your method too, ask your prescriber about backup or a non-oral method during your intake conversation rather than discovering it later, the way I nearly did.

How my first start actually looked

Once my gates were clear, the mechanics were the least dramatic part of the whole thing: pick a provider, answer the eligibility questions honestly, get matched to a starter dose, titrate up slowly over weeks. Scheduling a live video visit around a baby felt impossible to me, so it mattered enormously that some programs let you finish async, without a booked appointment — I cover which ones in getting a GLP-1 without a video visit. The one I'd point a friend to first is CoreAge Rx: flat pricing, both molecules, and an intake I finished in a single nap, and you can see exactly what that intake asks before you start. For the money side, here's the honest monthly cost. Two more things worth re-confirming right before you start, since your "when" might land weeks or months after you first looked around: Pomegranate Health sold compounded tirzepatide as recently as an earlier check, and as of an August 2026 visit its Weight Loss category lists only compounded semaglutide — a catalog that can move. MangoRx sells only an oral semaglutide tablet, marketed on its own landing page as "Medical Weight Loss for Men." And Ivologist prices the identical semaglutide program two different ways across two of its own pages, so read the one you're actually about to pay from. If knowing exactly who fills your prescription matters to you the way it mattered to me, Obu Health and Claya are two of the only compounders I've checked that name their actual pharmacies by street address instead of staying vague — worth a look if supply-chain transparency is on your checklist.

My first week was an adjustment and I logged all of it in week 1 on a GLP-1 as a mom of toddlers. Go slow, eat and hydrate around the nausea, and don't try to be a hero at the starter dose. I tried to be a hero at the starter dose.

The gates took me four months to clear, and I resented every one of them at the time. Clearing them with my prescriber is also the reason starting was boring when it finally happened, and boring is exactly what I wanted from a medication I was taking in the same house as a baby.